Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study for Evaluation of Acute Phase Safety and Efficacy of 'Pivot Bridge' to Short-term Treat Functional Tricuspid Regurgitation

NCT07385625 is registered in ClinicalTrials.gov with Tau-MEDICAL Co., Ltd. as lead sponsor.

NCT NCT07385625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07385625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study for Evaluation of Acute Phase Safety and Efficacy of 'Pivot Bridge' to Short-term Treat Functional Tricuspid Regurgitation
Lead sponsor
Tau-MEDICAL Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
November 20, 2025
Completion date
June 30, 2027
Enrollment
20 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid regurgitation functional